Media inquiries should be directed to:

Megan Airton
Manager, Communications & Development
Canadian Genetic Diseases Network
Phone: (604) 221-7300 ext. 110
Fax: (604) 221-0778
Email: [email protected]

	2004/03/25 - CGDN's Role in Economic Growth in Canada Validated by $76M CDN Funding for Aspreva Pharmaceuticals
	2004/01/26 - Leprosy Susceptibility Genes Identified
	2003/11/02 - New Discovery Points To Protection From Malaria
	2003/09/12 - New Discovery Sheds Light on Breast Cancer
	2003/09/09 - Scientists discover gene related to severe form of teenage epilepsy
	2003/08/18 - UBC Bioinformatics Centre - New Resources for CGDN Scientists
	2003/04/11 - Human Chromosome 7 Deciphered
	2003/03/25 - Steven Narod Appointed Tier 1 Canada Research Chair in Public Health Sciences
	2003/03/08 - Scientists Identify Gene Leading to Heart Failure
	2003/02/10 - Host Gene That Makes People Vulnerable to Leprosy Discovered
	2003/01/24 - CGDN to Collaborate with Sick Kids and ITRI to Produce Gene Chips for Research and Clinical Diagnostics
	2003/01/21 - CGDN Investigator Discovers Gene for Shwachman-Diamond Syndrome
	2003/01/20 - Researchers Collaborate to Identify Gene that Confers Resistance to Legionella Infection
	2002/10/03 - Scriver MD/PhD Scholarship Awarded to Six Canadian Students
	2002/04/12 - Canadian Genetic Diseases Network (CGDN) scientist leads team in identifying DNA flanking region as trigger for genetic instability in family of neurological disorders
	2002/03/05 - Canadian Genetics Research Community Launches New $1 Million National Studentship Program
	2002/02/19 - CGDN & CIHR sign collaborative research and training agreement with the Max Planck Institute in Germany
	2002/01/01 - “Solutions” for Finding Genetic Mutations
	2000/09/01 - Taiwanese Delegation to Visit Vancouver
	2000/03/17 - Researchers Discover Retinal Stem Cells in Adult Mammals
	1999/06/01 - Scientists Pinpoint Region for Cystic Fibrosis Modifier Gene
	1999/05/27 - Scientists Develop First Mouse Model to Reproduce Cardinal Features of Huntington Disease
	1999/03/03 - CGDN Acquires Equity Stake in Algene
	1999/03/03 - Scriver Research Group Anticipates Relief for PKU Sufferers
	1998/09/28 - Scientists Find Gene for Severe Form of Epilepsy
	1998/08/31 - Canadian Scientists Make Important Advance in the Study of Human Blood Disease
	1998/06/01 - Important Scientific Advance Affects Research on Bone Tumors in Children
	1998/06/01 - Board Appoints Ron Woznow as CEO - To Manage Commercial Interest of Newly Incorporated Network
	1998/01/28 - CGDN Scientists Report Advances in Huntington Disease and Rare Muscle Disease OPMD
	1997/11/14 - Canadian Scientist Heads Discovery of Gene Leading to Inherited Blindness
	1997/05/01 - Network Scientists Launch "Neurovir", a New International Biotechnology Company
	1996/11/01 - Scientists Discover Major Fanconi Anemia Gene
	1996/11/01 - Gene Responsible for 'Cyclops' Syndrome Discovered by Canadian Scientists
	1996/08/22 - Scientists Collaborate in Discovery of MADR2 Gene Associated with Colon Cancer
	1996/08/02 - Network Scientists Lap-Chee Tsui and Charles Scriver Receive National Honours
	1996/08/01 - Molecular Diagnostics for Childhood Eye Cancer can provide Signficiant Savings in Health Care Costs
	1996/04/01 - Scientific Advances in Fanconi Anemia and Eye Disease
	1996/04/01 - Canadian Scientist Discovers Location of New Gene Associated with Juvenile Diabetes
	1996/02/28 - Network Scientist Appointed Director of Ottawa General Hospital Research Institute
	1996/01/25 - Network Scientists Identify Key Genes Regulating Apoptosis (Programmed Cell Death)
	1996/01/02 - Two Canadian Researchers Make Major Advane in Understanding Cause of Fragile X Syndrome
	1995/12/20 - Canadian Scientists are Members of Team Discovering Second Gene for Hereditary Breast Cancer
	1995/12/18 - CGDN Endorses $US20 Million Research Partnership between University of Ottawa and the Research Development Corporation of Japan
	1995/12/05 - Second Gene for Early-Onset Alzheimer's Disease Discovered by Canadian Scientist
	1995/12/04 - Network Partnership Creates Apoptogen, Inc., a New Commercial Venture in Ottawa
	1995/07/01 - Canadian Scientist Leads Discovery of Gene for Early-Onset Alzheimer's Disease
	1995/06/01 - A First in Huntington Disease Research: Scientists Discover new functions of HD gene
	1995/01/12 - CGDN Collaborates in the Discovery of the Gene Responsible for Spinal Muscular Atophy (SMA)
	1995/01/01 - CGDN Scientists in Montreal and Toronto Make Breakthroughs in Three Genetic Diseases
	1994/11/28 - Canadian Study Leads to Genetic Test for Breast and Ovarian Cancer
	1992/09/01 - Merck Invests $15 Million to Create Centre for Molecular Medicine and Therapeutics

Please contact us to request any additional information concerning the Canadian
Genetic Disease Network.